KEGG   DRUG: Dasabuvir, ombitasvir, paritaprevir and ritonavirHelp
Entry
D10582            Mixture   Drug                                   

Name
Dasabuvir, ombitasvir, paritaprevir and ritonavir;
Viekira pak (TN)
Product
Component
(Dasabuvir sodium hydrate [DR:D10581] | Dasabuvir [DR:D10553]), (Ombitasvir hydrate [DR:D10598] | Ombitasvir [DR:D10576]), (Paritaprevir hydrate [DR:D10597] | Paritaprevir [DR:D10580]), Ritonavir [DR:D00427]
Remark
ATC code: J05AP52
Product: D10582<US>
Efficacy
Antiviral
  Disease
Chronic hepatitis C virus infection [DS:H00413]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AP Antivirals for treatment of HCV infections
     J05AP52 Dasabuvir, ombitasvir, paritaprevir and ritonavir
      D10582  Dasabuvir, ombitasvir, paritaprevir and ritonavir <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-hepatitis C (HCV) Agents, Direct Acting
   Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir
    D10582  Dasabuvir, ombitasvir, paritaprevir and ritonavir
Antiinfectives [br08350.html]
 Antivirals
  D10582
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10582
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10582
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and mutations affecting drug response
  D10582
BRITE hierarchy
Other DBs
PubChem: 254741544
ChEBI: 85177
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system